Get the Stockscreener App
2.80
3.32%
0.09
After Hours:
2.74
-0.06
-2.14%
Fortress Biotech Inc stock is traded at $2.80, with a volume of 416.52K.
It is up +3.32% in the last 24 hours and down -28.02% over the past month.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
See More
Previous Close:
$2.71
Open:
$2.71
24h Volume:
416.52K
Relative Volume:
0.46
Market Cap:
$83.31M
Revenue:
$80.97M
Net Income/Loss:
$-78.31M
P/E Ratio:
-0.2526
EPS:
-11.0849
Net Cash Flow:
$-129.56M
1W Performance:
-9.97%
1M Performance:
-28.02%
6M Performance:
+91.78%
1Y Performance:
+71.78%
1-Day Range:
$2.70
$2.83
1-Week Range:
$2.70
$3.24
52-Week Range:
$1.325
$4.20
Fortress Biotech Inc Stock (FBIO) Company Profile
Name
Fortress Biotech Inc
Sector
Industry
Phone
781-652-4500
Address
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
Compare FBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FBIO
Fortress Biotech Inc
|
2.80 | 80.64M | 80.97M | -78.31M | -129.56M | -11.08 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-15-24 | Resumed | ROTH MKM | Buy |
| Aug-04-22 | Initiated | Ladenburg Thalmann | Buy |
| Oct-02-20 | Initiated | The Benchmark Company | Buy |
| Dec-18-19 | Initiated | B. Riley FBR | Buy |
| Feb-28-18 | Initiated | B. Riley FBR, Inc. | Buy |
| Jul-11-17 | Initiated | Rodman & Renshaw | Buy |
| Mar-22-17 | Initiated | JMP Securities | Mkt Outperform |
| Oct-03-16 | Initiated | ROTH Capital | Buy |
View All
Fortress Biotech Inc Stock (FBIO) Latest News
Can Fortress Biotech Inc. recover in the next quarterJuly 2025 Trends & Real-Time Market Sentiment Alerts - newser.com
Real time alert setup for Fortress Biotech Inc. performanceQuarterly Earnings Summary & Smart Swing Trading Techniques - newser.com
Applying Wyckoff theory to Fortress Biotech Inc. stockRisk Management & Technical Confirmation Alerts - newser.com
Trend analysis for Fortress Biotech Inc. this weekMarket Weekly Review & Weekly High Return Forecasts - newser.com
Is Fortress Biotech Inc. stock reversal real or fakeQuarterly Earnings Summary & Verified Momentum Stock Ideas - newser.com
Fortress Biotech (NASDAQ:FBIOP) Stock Price Down 1.7% – What’s Next? - Defense World
Will Fortress Biotech Inc.(CNB0) stock beat Nasdaq index returnsGap Up & Weekly High Conviction Ideas - newser.com
Real time breakdown of Fortress Biotech Inc. stock performanceQuarterly Profit Report & Growth Focused Entry Reports - newser.com
Predicting Fortress Biotech Inc. trend using moving averagesQuarterly Market Summary & Verified Momentum Stock Alerts - newser.com
Fortress Biotech's (FBIO) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Using fundamentals and technicals on Fortress Biotech Inc.Market Volume Report & Weekly Chart Analysis and Trade Guides - newser.com
Fortress Biotech’s (FBIO) “Sell (D-)” Rating Reaffirmed at Weiss Ratings - Defense World
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc.FBIO - PR Newswire
What the charts say about Fortress Biotech Inc. today2025 Trade Ideas & Verified Swing Trading Watchlist - newser.com
Will Fortress Biotech Inc. outperform the marketJuly 2025 Selloffs & Intraday High Probability Setup Alerts - newser.com
What data driven models say about Fortress Biotech Inc.’s future2025 Market Sentiment & Safe Entry Trade Reports - newser.com
Real time social sentiment graph for Fortress Biotech Inc.2025 Key Highlights & Detailed Earnings Play Alerts - newser.com
Tools to monitor Fortress Biotech Inc. recovery probability2025 Top Gainers & Daily Profit Maximizing Tips - newser.com
Revenues Working Against Fortress Biotech, Inc.'s (NASDAQ:FBIO) Share Price Following 26% Dive - simplywall.st
What catalysts could drive Fortress Biotech Inc. stock higherWeekly Stock Recap & Weekly High Return Forecasts - newser.com
Published on: 2025-10-05 05:38:39 - newser.com
What insider purchases suggest about Fortress Biotech Inc.(CNB0) stockJuly 2025 Fed Impact & Weekly High Return Opportunities - newser.com
Fortress Biotech, Inc. Securities Lawsuit Investigation - Claim Depot
Leading vs lagging indicators on Fortress Biotech Inc. performance2025 Analyst Calls & Reliable Volume Spike Alerts - newser.com
Will Fortress Biotech Inc.(CNB0) stock outperform foreign stocks2025 Technical Overview & Weekly High Return Stock Forecasts - newser.com
Published on: 2025-10-03 04:06:28 - newser.com
Applying Elliott Wave Theory to Fortress Biotech Inc.Weekly Stock Analysis & Free Fast Gain Swing Trade Alerts - newser.com
Head to Head Analysis: Fortress Biotech (NASDAQ:FBIO) & Amarin (NASDAQ:AMRN) - Defense World
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics $205 Million Series a Financing - MarketScreener
Big Announcements Hammer Biotech And AI Shares - Finimize
Fortress Biotech Investigated by the Portnoy Law Firm - GlobeNewswire
Fortress Biotech Investigated by the Portnoy Law Firm - GlobeNewswire Inc.
Why Is Fortress Biotech Stock Falling Today? - NewsBreak: Local News & Alerts
INVESTOR ALERT: Investigation of Fortress Biotech, Inc. (FBIO) Announced by Holzer & Holzer, LLC - GlobeNewswire
Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility - MarketScreener
Fortress Biotech shares tumble after FDA rejection of Menkes treatment - MSN
US FDA declines to approve Fortress Bio and Zydus' treatment for a rare pediatric disease - Reuters
Fortress Biotech Inc Stock (FBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):